The wound healing assay indicated that the activation of p-ERK1/2 ameliorated the inhibitory effect of NCOA7 overexpression on the migration of ccRCC cells (Figure 8A,B). The gene discussed is MAPK3; the disease is nonpapillary renal cell carcinoma.